X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4242) 4242
Newsletter (149) 149
Book Chapter (13) 13
Magazine Article (8) 8
Dissertation (2) 2
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3496) 3496
science & technology (3329) 3329
life sciences & biomedicine (2973) 2973
viremia (2366) 2366
male (2151) 2151
female (2073) 2073
adult (1764) 1764
infectious diseases (1458) 1458
middle aged (1436) 1436
hiv infections - drug therapy (1423) 1423
viral load (1321) 1321
immunology (1194) 1194
viremia - drug therapy (1092) 1092
hiv (1052) 1052
hiv infections - virology (1049) 1049
virology (1040) 1040
viremia - virology (916) 916
aids/hiv (793) 793
health aspects (755) 755
rna, viral - blood (754) 754
antiviral agents - therapeutic use (746) 746
anti-hiv agents - therapeutic use (745) 745
infections (728) 728
viruses (696) 696
virus diseases (693) 693
hiv infections - immunology (682) 682
cd4 lymphocyte count (652) 652
human immunodeficiency virus--hiv (647) 647
hiv infection (640) 640
antiviral agents (624) 624
microbiology (615) 615
drug therapy (596) 596
research (593) 593
treatment outcome (558) 558
antiretroviral therapy, highly active (534) 534
aged (530) 530
viremia - immunology (513) 513
abridged index medicus (492) 492
animals (492) 492
highly active antiretroviral therapy (465) 465
drug therapy, combination (464) 464
hiv-1 - genetics (462) 462
antiretroviral therapy (457) 457
transplantation (455) 455
antiretroviral drugs (444) 444
aids (443) 443
risk factors (443) 443
adolescent (433) 433
analysis (402) 402
care and treatment (390) 390
research article (390) 390
hiv-1 - drug effects (385) 385
rna (374) 374
measurement (360) 360
time factors (358) 358
science & technology - other topics (357) 357
multidisciplinary sciences (356) 356
medicine (347) 347
hiv-1 - isolation & purification (343) 343
polymerase chain reaction (340) 340
prospective studies (338) 338
dna, viral - blood (337) 337
human immunodeficiency virus (335) 335
retrospective studies (329) 329
young adult (328) 328
cd4 antigen (327) 327
patients (325) 325
hiv-1 - physiology (317) 317
gastroenterology & hepatology (316) 316
hepatitis c (306) 306
genotype (304) 304
cohort studies (300) 300
acquired immune deficiency syndrome--aids (298) 298
hiv-1 (293) 293
hepatitis (278) 278
viremia - diagnosis (276) 276
medical research (275) 275
hepacivirus - genetics (264) 264
science (261) 261
child (255) 255
antiretroviral agents (251) 251
cd4-positive t-lymphocytes - immunology (251) 251
hiv-1 - immunology (250) 250
t cells (247) 247
hepatitis c, chronic - drug therapy (245) 245
hiv infections - complications (241) 241
hepatitis c virus (240) 240
lymphocytes t (239) 239
follow-up studies (238) 238
drug resistance (237) 237
cytomegalovirus (233) 233
interferon-alpha - therapeutic use (223) 223
lymphocytes (223) 223
anti-hiv agents - administration & dosage (221) 221
ribonucleic acid--rna (215) 215
virus replication (215) 215
hiv infections - blood (214) 214
interferon (214) 214
antiviral agents - administration & dosage (213) 213
hematology (213) 213
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4309) 4309
Spanish (59) 59
French (31) 31
Italian (12) 12
Portuguese (11) 11
Chinese (9) 9
German (9) 9
Japanese (9) 9
Russian (9) 9
Czech (3) 3
Korean (2) 2
Polish (2) 2
Turkish (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 1476-4687, 07/2012, Volume 487, Issue 7408, pp. 482 - 485
Journal Article
Nature (London), ISSN 1476-4687, 09/2018, Volume 561, Issue 7724, pp. 479 - 484
Individuals infected with HIV-1 require lifelong antiretroviral therapy, because interruption of treatment leads to rapid rebound viraemia... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Drug Resistance, Viral | Antibodies, Monoclonal - therapeutic use | Male | Phylogeny | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | HIV-1 - isolation & purification | Antibodies, Neutralizing - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Antibodies, Monoclonal - immunology | Carrier State - immunology | HIV Infections - virology | Viremia - drug therapy | HIV Antibodies - administration & dosage | Carrier State - virology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | Viremia - prevention & control | Adolescent | Carrier State - drug therapy | HIV Infections - drug therapy | Viremia - immunology | Aged | HIV Envelope Protein gp160 - immunology | Infusions, Intravenous | Binding Sites, Antibody | Virus Activation - immunology | Virus Latency - immunology | Anti-HIV Agents - immunology | Drug Combinations | Physiological aspects | HIV patients | Care and treatment | Drug therapy, Combination | HIV antibodies | Antiretroviral drugs | Therapy | Antiviral agents | Interruption | Immunoglobulins | Viremia | Clinical trials | Viruses | Infections | Genomes | Antiretroviral therapy | Antiretroviral agents | Lymphocytes | Human immunodeficiency virus--HIV | Monoclonal antibodies | Drug therapy | Bioinformatics | Binding sites | Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 09/2016, Volume 45, Issue 3, pp. 656 - 668
Journal Article
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 05/2013, Volume 123, Issue 6, pp. 2604 - 2615
... in a phenotype resembling that of memory T cells. Surprisingly, IL-2 therapy had only a minimal effect on reducing viral load. However, combining IL-2 treatment... 
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lymphocytic choriomeningitis virus - immunology | Arenaviridae Infections - virology | Humans | Lymphocytic choriomeningitis virus - drug effects | T-Lymphocytes, Regulatory - immunology | Interleukin-2 - administration & dosage | Immunotherapy | Hyaluronan Receptors - metabolism | CD8-Positive T-Lymphocytes - metabolism | Female | Arenaviridae Infections - immunology | Antiviral Agents - pharmacology | Lymphocyte Activation | Mice, Inbred C57BL | Immunologic Factors - administration & dosage | Programmed Cell Death 1 Receptor - metabolism | Mice, Transgenic | Viremia - drug therapy | Antiviral Agents - administration & dosage | B7-H1 Antigen - immunology | Antibodies - pharmacology | Drug Synergism | Antibodies - administration & dosage | T-Lymphocytes, Regulatory - drug effects | Animals | B7-H1 Antigen - antagonists & inhibitors | Arenaviridae Infections - drug therapy | Viremia - virology | CD8-Positive T-Lymphocytes - virology | CD8-Positive T-Lymphocytes - drug effects | Interleukin-7 Receptor alpha Subunit - metabolism | Interleukin-2 - pharmacology | Viremia - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Viral Load - drug effects | Chronic Disease | Immunologic Factors - pharmacology | Care and treatment | Interleukin-2 | Genetic aspects | Research | T cells | Health aspects | Apoptosis | Cancer | Studies | Antiretroviral drugs | Cytokines | Lymphocytes | Infections | T cell receptors | Drug dosages | Cancer therapies | Viral infections | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, pp. e0164753 - e0164753
.... One subject discontinued the study drug at week 24 for headache, one for drug interaction and one died after week 24 of illicit drug abuse... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Headache - etiology | Follow-Up Studies | Humans | Middle Aged | Drug Resistance, Viral | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - adverse effects | Rilpivirine - therapeutic use | Drug Interactions | HIV-1 - isolation & purification | Rilpivirine - adverse effects | Adult | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Sleep Initiation and Maintenance Disorders - etiology | Drug Administration Schedule | HIV Infections - virology | HIV-1 - genetics | Antiretroviral Therapy, Highly Active | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | Creatinine - blood | HIV Infections - drug therapy | Aged | Cohort Studies | Virus diseases | DNA polymerases | RNA | Proteases | Headache | Drug abuse | RNA-directed DNA polymerase | Toxicity | Viremia | Clinical trials | Viruses | Ethics | Sleep disorders | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Drug interaction | Drug therapy | Creatinine | Antiretroviral drugs | Level (quantity) | Life expectancy | Drug interactions | Metabolism | Ribonucleic acid--RNA | Infectious diseases | Insomnia | Collaboration | Clinical medicine | Mutation | Females | Index Medicus | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 03/2014, Volume 111, Issue 19, pp. 7078 - 7083
Journal Article
PLoS medicine, ISSN 1549-1676, 11/2017, Volume 14, Issue 11, pp. e1002432 - e1002432
Journal Article